EP3179992
Meðferðarsamsetningar BTK hemils, PD-1 hemils og/eða PD-L1 hemils
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.8.2015EP published:
11.5.2022EP application number:
15762756.3
EP translation filed:
13.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
10.8.2035Expiry date:
10.8.2026Next due date:
31.8.2026
Title in English:
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PD-1 INHIBITOR AND/OR A PD-L1 INHIBITORLanguage of the patent:
English
Timeline
Today
11.8.2015EP application
11.5.2022EP Publication
13.6.2022Translation submitted
15.7.2022Registration published
10.8.2026Expires
Owner
Name:
Acerta Pharma B.V.Address:
Kloosterstraat 9, 5349 AB Oss, NL
Inventor
Name:
HAMDY, AhmedAddress:
Santa Cruz, CA 95060, US
Name:
ROTHBAUM, WayneAddress:
New York, NY 10023, US
Name:
IZUMI, RaquelAddress:
San Carlos, CA 94070, US
Name:
LANNUTTI, BrianAddress:
Solana Beach, CA 92075, US
Name:
COVEY, ToddAddress:
San Carlos, CA 94070, US
Name:
ULRICH, RogerAddress:
Sammamish,WA 98075, US
Name:
JOHNSON, DaveAddress:
Aptos, CA 95033, US
Name:
BARF, TjeerdAddress:
5371 AS Ravenstein, NL
Name:
KAPTEIN, AllardAddress:
5301 HB Zaltbommel, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462035812 PDate:
11.8.2014Country:
US
Number:
201462088357 PDate:
5.12.2014Country:
US
Number:
201562115489 PDate:
12.2.2015Country:
US
Number:
201562181164 PDate:
17.6.2015Country:
US
Classification
Categories:
A61K 39/395, A61K 31/00, A61K 31/4155, A61K 31/416, A61K 31/454, A61K 31/519, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 2.8.2022
Expires: 10.8.2023
Payer: Patice ehf.
Number: 9
Paid: 3.8.2023
Expires: 10.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.7.2024
Expires: 10.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.8.2025
Expires: 10.8.2026
Payer: Árnason Faktor ehf.